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The vagus nerve innervates visceral organs providing
a link between key metabolic cues and the CNS.
However, it is not clear whether vagal neurons can
directly respond to changing lipid levels and whether
altered ‘‘lipid sensing’’ by the vagus nerve regulates
energy balance. In this study, we systematically
profiled the expression of all known nuclear recep-
tors in laser-captured nodose ganglion (NG) neurons.
In particular, we found PPARg expression was
reduced by high-fat-diet feeding. Deletion of PPARg
in Phox2b neurons promoted HFD-induced thermo-
genesis that involved the reprograming of white
adipocyte into a brown-like adipocyte cell fate.
Finally, we showed that PPARg in NG neurons regu-
lates genes necessary for lipidmetabolism and those
that are important for synaptic transmission. Collec-
tively, our findings provide insights into how vagal
afferents survey peripheral metabolic cues and
suggest that the reduction of PPARg in NG neurons
may serve as a protective mechanism against diet-
induced weight gain.
INTRODUCTION
The obesity epidemic is spreading at an accelerated pace,
currently affecting more than 500 million people around the
world. While it is well appreciated that excessive nutrients from
a fat- and carbohydrate-rich diet are responsible for obesity
and its comorbid conditions (Unger and Scherer, 2010), much
of how nutritional status is regulated at the organismal level re-
mains to be understood. The metabolic status of visceral organs
is conveyed in part by circulating hormones such as leptin and
insulin that can act directly upon discrete neural pathways in
the central nervous system (CNS) to regulate energy balance
(Myers and Olson, 2012). Notably, a second and less-appreci-
ated pathway exists involving direct neuronal innervation by sen-
sory afferents of the spinal and vagus nerves. In particular, vagal
sensory neurons in the nodose ganglion (NG) densely innervate722 Cell Metabolism 19, 722–730, April 1, 2014 ª2014 Elsevier Inc.key visceral organs such as the liver, portal vein, and the gastro-
intestinal (GI) tract. Moreover, these neurons send ascending
projections to the nucleus of solitary tract (NTS) in the brain
where incoming visceral information is further processed and in-
tegrated (Berthoud, 2008). Therefore, it has long been hypothe-
sized that vagal sensory neurons are anatomically positioned to
serve as a link between changing levels of peripheral metabolic
cues and the CNS pathways that control energy homeostasis.
Accumulating evidence arising from physiological (Chi and
Powley, 2007; Tellez et al., 2013;Wang et al., 2008), electrophys-
iological (Lal et al., 2001; Randich et al., 2000), and biochemical
(de Lartigue et al., 2011; Duca et al., 2013; Paulino et al., 2009)
studies have established that vagal sensory neurons respond
to both acute and long-term changes in nutritional status
including that of dietary-derived lipids. The acute response of
vagal afferents to intestinal lipids are thought to be regulated
by gut peptides and neurotransmitters that are transiently
released from the neighboring enteroendocrine cells (Glatzle
et al., 2003; Raybould et al., 1998; Moran et al., 1997). However,
it remains unclear whether vagal sensory neurons themselves
have the capacity to directly sense peripheral lipid status and
whether altered lipid sensing by the vagus nerve can impair
long-term energy and glucose homeostasis.
To identify candidate genes and pathways that may play a
role in the vagal control of lipid sensing, we purified RNA from
vagal sensory neurons in the NG and subjected them to
genome-wide gene expression analysis. Our profiling studies
of NG neurons revealed an unexpected enrichment of nuclear re-
ceptors (NRs) in particular, peroxisome proliferator-activated re-
ceptor g (PPARg), that are ligand-activated transcription factors
and receptors for many dietary-derived lipids (Chawla et al.,
2001). The enrichment of several ‘‘lipid sensors’’ such as PPARg
in NG neurons therefore raised the possibility that NRs in vagal
sensory neurons modulate energy balance by directly sensing
changing levels of peripheral metabolic cues. Despite its well-
documented role in lipid metabolism in peripheral organs,
PPARg function in vagal sensory neurons remains to be estab-
lished. In the current study, we investigated the physiological
role of PPARg by genetically ablating its expression in vagal neu-
rons. Our findings revealed a role for PPARg in vagal sensory
neurons in sensing and relaying peripheral lipid status toward
the CNS and highlight the role of the vagus nerve as a critical
site where PPARg modulates energy homeostasis.
Figure 1. NR Expression in the NG
(A) Laser-guided microdissection of neuron-enriched samples from thionin-counterstained nodose ganglia. Neuron-enriched areas appear darkly counter-
stained, as opposed to unstained regions, which contain mostly fibers and glial cells.
(B) Relative levels of NR expression are indicated by the pie chart and shown in the tables to the right.
(C–F) In situ hybridization of select lipid-sensing NRs in the NG. Clusters of silver grains (35S) indicate mRNA expression of LXRa (C), LXRb (D), PPARg (E),
and PPARa (F).
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Profiling Nuclear Receptor Expression in the NG
We have previously established a high-throughput quantitative
real-time PCR (qPCR) assay to examine NR expression in
peripheral tissues and in the CNS (Bookout et al., 2006). Using
this approach, we investigated the expression patterns of all
known murine NRs in the NG of male C57BL/6 mice. RNA
was extracted from the left NG, in which the residing vagal sen-
sory neurons predominantly innervate metabolically important
abdominal viscera (e.g., pancreas, GI tract, and liver). In order
to minimize RNA contamination from the epineurium of periph-
eral nerves, cell bodies of NG neurons were isolated by laser
capture microdissection (Figure 1A). Our analysis identified tran-
scripts of 34 NRs (out of the 49 known NRs) in the NG (Fig-
ure 1B). Notably, we found several NRs that are important for
lipid metabolism and energy balance were expressed at
moderate to high levels in NG neurons (Figure 1B). These
include glucocorticoid receptor, liver X receptor-a, and liver X
receptor-b (LXRa and LXRb), which act in a variety of cell types,
including CNS neurons to control distinct aspects of nutrient
metabolism (Chawla et al., 2001). Moreover, PPARa and
PPARg, known as dietary lipid sensors in the liver and adipose
tissue, respectively, were expressed in the NG (Figure 1B).
Furthermore, members of the retinoid X receptor family, which
act as heterodimer partners to PPARs (Chawla et al., 2001),
were also expressed in the NG (Figure 1B). Expression of
selected NRs in the NG was further verified by in situ hybridiza-
tion with 35S-labeled riboprobes (Figures 1C–1F).
High-Fat-Diet Feeding Reduces PPARg Expression in
the NG
NRs directly bind dietary-derived lipids to alter target gene
expression in response to internal and external cues (Chawla
et al., 2001). We investigated whether PPARg expression in
the NG was nutritionally regulated by challenging the mice
with HFD (42% kcal from fat). Eight-week-old C57BL/6 miceCwere fed ad libitum on either regular chow (4% kcal from fat)
or HFD for a total of 14 weeks before being sacrificed for
gene expression analysis. We found that the expression of
PPARg mRNA was significantly reduced in NG neurons after
chronic exposure to HFD (Figure 2A), whereas levels of PPARd
as well as the two LXR receptors (LXRa and LXRb) remained
unchanged (Figures 2B–2D). We further examined whether a
short-term exposure to HFD would result in a similar reduction
of these receptors in NG neurons. Remarkably, levels of PPARg
decreased after only 5 days of HFD feeding (Figure 2E). In
comparison, its levels in white adipose tissue (WAT) and brown
adipose tissue (BAT) remained constant during this period (Fig-
ure S1 available online). Notably, several canonical transcrip-
tional targets of PPARg that are important for lipid metabolism
were also present in the NG. Their levels were significantly
reduced after 5 days of HFD feeding (Figure 2F) and remained
suppressed after chronic HFD exposure (data not shown). Inter-
estingly, we found that HFD reliably alters the expression
PPARg and its transcriptional targets in NG neurons. However,
treatment with the PPARg selective agonist, rosiglitazone, did
not (Figures S1D–S1G). This finding suggests that HFD and
rosiglitazone may activate PPARg through distinct mechanisms
to modulate different cellular functions in NG neurons (Choi
et al., 2010).
Ablation of PPARg in Phox2b Neurons
The downregulation of PPARg in the NG neurons after HFD
feeding raised the intriguing possibility that it played a role in
mediating HFD-induced metabolic alterations. One critical way
to test this hypothesis is to selectively ablate PPARg function
in vagal afferents and investigate whether this contributes to
HFD-induced thermogenesis and/or metabolic syndrome. While
PPARg function has been characterized in several peripheral
organs, its expression pattern and function in the nervous sys-
tem has not been well studied. To this end, we first assessed
PPARg expression in laser-captured neurons collected from
distinct neuronal populations in the peripheral and centralell Metabolism 19, 722–730, April 1, 2014 ª2014 Elsevier Inc. 723
Figure 2. NR Expression in Nodose Neu-
rons after Long- and Short-Term Feeding
with HFD
(A–D) Relative mRNA levels of PPARg (A),
PPARd(B), LXRa(C), and LXRb(D) in the NG after
14weeks of feedingwith either chow (n = 6) or HFD
(n = 8). Error bars show SEM. The symbol * in-
dicates p < 0.05.
(E and F) Relative gene expression in the NG after
3-day and 5-day feeding with either chow (n = 10)
or HFD (n = 10). Error bars show SEM. * indicates
p < 0.05.
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abundantly expressed in the NG, whereas its expression was
markedly lower in the spinal dorsal root ganglion (Figure S2A).
In the brain, our analysis detected strong PPARg expression in
the cerebral cortex and the organum vasculosum of the lamina
terminalis (Figure S2B), a pattern that is consistent with previous
report (Gofflot et al., 2007) and with our own observations by
in situ hybridization (data not shown). Notably, PPARg was pre-
sent at low levels in the NTS, a target of incoming vagal sensory
information, whereas it was not detectable in the dorsal motor
nucleus of the vagus, the parasympathetic motor output of the
vagus nerves (Figure S2B).
To ablate PPARg function in vagal sensory neurons, we bred
floxed PPARg mice (He et al., 2003) with mice that express
bacteriophage-derived Cre recombinase driven by the regula-
tory sequences of the Phox2b gene (Scott et al., 2011). Phox2b
is a homeodomain transcription factor that plays an essential
role in the differentiation of the visceral nervous system (Pattyn
et al., 1999). We have previously generated and characterized a
transgenic Phox2b::Cre line that showed restricted Cre expres-
sion in the peripheral nervous system (Rossi et al., 2011). Cre
activity was detected in all neurons in the NG but was absent
from other sympathetic or parasympathetic ganglia (Gautron
et al., 2013; Scott et al., 2011). Notably, Phox2b::Cre was pre-
sent in the second-order visceral sensory neurons in the NTS.
Therefore, using the Phox2b::Cre allows for the ablation of
PPARg function in both central and peripheral branches of the
vagal afferents.
Removal of the floxed exons of PPARg gene generates
truncated and nonfunctional PPARg transcripts that can be
detected by PCR. We therefore assessed the expression of724 Cell Metabolism 19, 722–730, April 1, 2014 ª2014 Elsevier Inc.the full-length as well as the truncated
PPARg transcripts in peripheral tissues
and inmultiple brain sites of Phox2b::Cre;
PPARgfl/fl mice. Cre-mediated ablation
could only be detected in the NG and in
the brainstem. Recombination was not
found in any forebrain structures nor in
other peripheral organs that we examined
(Figure S2D). We further assessed the
levels of full-length PPARg transcripts in
the NG using a Taqman probe that didn’t
recognize the truncated isoforms. Our
analysis revealed that PPARg mRNA
expression was comparable betweenPPARgfl/fl and Phox2b::Cre; PPARgfl/+ mice, whereas their levels
were significantly reduced in Phox2b::Cre; PPARgfl/fl mice
(Figure S2C).
PPARg in Phox2b Neurons Regulates Body Weight and
Composition
To determine whether PPARg function in the vagal afferents is
required for normal energy homeostasis, we conducted meta-
bolic analysis using Phox2b::Cre; PPARgfl/fl (designated here-
after as PPARgPhox2b KO) mice and their littermate controls
(Phox2b::Cre; PPARgfl/+). We found no significant differences
in glycemia or lipidemia between PPARgPhox2b KO mice and their
littermate controls (Figures S3A–S3J). Moreover, chow-fed
PPARgPhox2b KO mice initially had comparable body weights
to their littermate controls until 13 weeks of age. However,
body weights began to diverge at 14 weeks of age as
PPARgPhox2b KO mice gained less weight and became signifi-
cantly leaner than their littermates at 17 weeks of age (Fig-
ure S4A). This lean phenotype was more prominent when
PPARgPhox2b KO mice were fed on HFD, as their body weights
diverged much earlier and faster (Figures S4B and S4D). Under
both dietary conditions, nuclear magnetic resonance analysis
revealed that the decreased body weight in PPARgPhox2b KO
mice was due to a reduction in the fat mass, but not in the lean
mass (Figure S4C).
We probed whether the decreased body weight in
PPARgPhox2b KO mice was the result of a reduction in food
intake. Surprisingly, in weight-matched mice, we found no
differences in the cumulative food intake over a 5 day period
(Figure S4G). Moreover, daily intake during the light and dark
cycles was comparable between PPARgPhox2b KO mice and their
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‘‘refeeding’’ paradigm in which food intake was measured after
an overnight fast and found no differences between the geno-
types (Figure S4I).
PPARg in Phox2b Neurons Regulates Energy
Expenditure
To further investigate the lean phenotype, a new cohort of
PPARgPhox2b KO mice and their littermate controls were as-
sessed in the metabolic chambers. All experiments were con-
ducted in weight-matched male mice before differences in
body weight became evident (Figure 3A). Despite the divergence
of body weight at a later stage, indirect calorimetry analyses
failed to detect significant differences in energy expenditure
(EE) between chow-fed PPARgPhox2b KO and their littermate
controls when these mice were tested at 11 weeks of age (Fig-
ures 3B–3D). However, during a food-restriction challenge,
PPARgPhox2b KO lost more weight than their littermate controls
(Figures S4E and S4F), suggesting that these mice had higher
EE during the period of negative energy balance.
Increased EE was more evident when PPARgPhox2b KO mice
were fed HFD (Figures 3A–3D). These mice demonstrated signif-
icantly elevated levels of oxygen consumption (Figure 3B),
carbon dioxide, and heat production (Figures 3C and 3D) when
housed in themetabolic chambers. An increase in physical activ-
ity was also observed in PPARgPhox2b KO mice (Figure 3F),
whereas the respiratory exchange ratio remained unchanged
(Figure 3E). The HFD-exacerbated increase in EE was best
demonstrated when weight-matched PPARgPhox2b KO mice
and control littermates were acutely exposed to HFD. A
counter-regulatory increase in EE normally follows the switch
from regular chow diets to HFD, and this effect was exacerbated
in the PPARgPhox2b KO mice. Before the switch, the mice were
maintained on regular chow, and EE was comparable between
PPARgPhox2b KO mice and their littermate controls. As expected,
all mice demonstrated increases in EE after exposure to HFD
(Figures 3G–3L). However, the increases in oxygen consumption
(Figure 3J) and heat production (Figure 3L) were markedly higher
in PPARgPhox2b KO mice compared to the controls.
BAT is the major thermogenic organ in rodents and humans
(Cypess et al., 2009; van Marken Lichtenbelt et al., 2009; Virta-
nen et al., 2009). Different from the white adipocytes, brown
adipocytes contain many smaller lipid droplets and a much
higher number of mitochondria that are needed for heat produc-
tion (Harms and Seale, 2013). We examined the expression of
mitochondrial genes that are important for BAT thermogenesis
and found a mild but significant increase in uncoupling protein
1 (Ucp1) expression inHFD-fedPPARgPhox2b KOmice (Figure 4A).
Surprisingly, we found markedly increased expression of Ucp1,
as well as other brown adipocyte markers, in the subcutaneous
white fat depot of these mice (Figure 4B). Consistent with alter-
ations in gene expression, we found that the subcutaneous white
adipocytes of HFD-fed PPARgPhox2b KOmice had adopted a new
morphology (Figures 4C and 4D) and biomarker expression (Fig-
ures 4E and 4F) that were characteristic of brown adipocytes.
Collectively, this suggests a mechanism by which the increased
EE observed in PPARgPhox2b KO mice involves the active reprog-
raming of white adipocytes toward a brown adipocyte cell fate.
Since sympathetic inputs play important roles in both the brown-Cing of white adipocytes (Schulz et al., 2013) and diet-induced
thermogenesis (Bachman et al., 2002), we examined the
expression of b3-adrenergic receptor in brown and white adipo-
cytes and found that their levels were significantly elevated in
PPARgPhox2b KO mice (Figures 4A and 4B).
PPARg Regulates Gene Expression in the NG
At least two alternatively spliced PPARg isoforms have been
identified in mice and humans. Unlike the widely expressed
PPARg1 isoform, PPARg2 expression is largely restricted to
adipose tissues (Tontonoz et al., 1994). Using isoform-specific
probes, we found that NG neurons predominantly express the
PPARg2 isoform, and its levels were negatively regulated by
HFD feeding (Figure 4G). PPARg directs a transcriptional
program that governs lipid synthesis and storage in adipo-
cytes; however, its neuronal functions remain largely unex-
plored. To obtain molecular insights into how PPARgmodulates
neurophysiology in vagal sensory neurons, we conducted
genome-wide gene expression analysis and compared the tran-
scriptomes of laser-captured NG neurons of control and PPARg-
deficient mice. Our analysis identified hundreds of differentially
expressed genes (fold changeR2; p < 0.01) in PPARg-deficient
NG neurons. We then verified the changes of selected genes by
Taqman qPCR and found significant reduction of mRNAs of
several PPARg canonical transcriptional targets including
CD36, Lpl, and aP2 in PPARg-deficient NG neurons (Figure 4H).
Moreover, their expression in NG neurons was negatively regu-
lated by HFD in wild-type mice, but not in the PPARgPhox2b KO
mice (Figure S1C). In addition to genes involved in lipid meta-
bolism, we found many neuronal genes, including Synt4, Gria2,
Gria3, and Ntrk2, that are important for transmitter release, syn-
aptic transmission, and plasticity were also altered in PPARg-
deficient NG neurons (Figure 4I). While most of the differentially
expressed genes were downregulated in PPARg-deficient neu-
rons, we found a small number of genes which were upregulated
(Figure 4I). These include receptors for the anorexigenic peptide
cholecystokinin (CCK) (Moran and McHugh, 1982). To test
whether changes in gene expression have a physiological
impact on vagal-mediated behavior, we measured the food
intake in overnight-fasted control and PPARgPhox2b KO mice
following an acute intraperitoneal dose of saline or CCK. We
found no differences in the amount of food intake when these
mice were treated with saline (data not shown), whereas
PPARgPhox2b KO mice had an enhanced anorexic response to
CCK and consumed significantly less food during the refeeding
phase (Figure 4J).
DISCUSSION
The molecular mechanisms underlying nutrient sensing by the
vagus nerve have been difficult to elucidate. This is due in large
part to a relative lack of knowledge of the specific genes ex-
pressed in these neurons and the genetic tools that allow for their
manipulation in vivo. Our findings that vagal sensory neurons ex-
press several NRs, including PPARg, that can directly interact
with dietary-derived lipids provide insights into how vagal affer-
ents survey metabolic information from peripheral tissues and
gate this information to the brain. It remains to be determined
how PPARg physically interact with fatty acids (FAs) within vagalell Metabolism 19, 722–730, April 1, 2014 ª2014 Elsevier Inc. 725
Figure 3. PPARg in Phox2b Neurons Regulates Energy Expenditure
(A) Bodyweight of PPARgPhox2b KOmice and littermate controls on chow diet were followed over time (n = 11 per genotype). Arrow indicates the age at whichmice
were tested in metabolic cages.
(B–E) Energy expenditure in weight-matched mice.
(B) O2 consumption.
(C) CO2 production.
(D) Heat production.
(E) Respiratory exchange ratio.
(F) Locomotor activity.
(G–L) Response to acute HFD challenge. Traces of O2 consumption (G), CO2 production (H), and heat generation (I) during 12 hr light and dark cycles.
(J–L) Changes in O2 consumption (J), CO2 production (K), and heat production (L) of the same mice before and after the switch to HFD. Error bars show SEM.
The symbol * indicates p < 0.05.
Cell Metabolism
Vagal Control of Lipid Sensing and Energy Balancesensory neurons. It will be intriguing to investigate whether
PPARg shuttles from the nucleus to vagal sensory terminals to
directly capture circulating FAs. Alternatively, a second route
may involve vagal sensory neurons’ specialized ability to pro-
cess FAs via the expression of several ‘‘adipocyte’’ genes. For
example, the uptake of extracellular lipoproteins and long-chain726 Cell Metabolism 19, 722–730, April 1, 2014 ª2014 Elsevier Inc.FAs can be mediated by the scavenger receptor CD36 (Calvo
et al., 1998). Moreover, different lipoproteins can be processed
by lipoprotein lipases so that FAs are released and further tar-
geted to the nucleus by adipocyte protein 2 (aP2) (Tan et al.,
2002). We found that all these genes are expressed in vagal sen-
sory neurons and that their levels were markedly reduced in
Figure 4. White Adipocyte Reprogramming and Altered NG Gene Expression in PPARgPhox2b KO Mice
(A) Relative gene expression in BAT (n = 6 per genotype).
(B) Relative gene expression in subcutaneous. WAT (n = 6 per genotype). Error bars show SEM. The symbol * indicates p < 0.05.
(C and D) HE staining of subcutaneous WAT.
(E and F) Immunohistochemistry for UCP1 in subcutaneous WAT. Scale bar is 50 mm.
(G–J) PPARg regulates gene expression in the NG.
(G) Expression of PPARg1 and PPARg2 mRNA in the NG of wild-type mice fed with either chow or HFD. The symbol *** indicates p < 0.001.
(H) Relative expression of several canonical PPARg transcriptional targets expression in the NG.
(I) Relative expression of neuronal gene expression in the NG. a indicates p < 0.01; b indicates p < 0.05.
(J) Anorectic responses to CCK treatment in PPARgPhox2b KO and control mice. Data are shown as percentage of food intake (CCK)/food intake (Saline). n = 11
to 13; * indicates p < 0.05 comparing food intake in the same animals treated with saline and CCK.
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PPARg directs a transcriptional program that governs the vagal
sensing of FAs within NG neurons.
Similar to its function in adipocyte differentiation and lipid stor-
age, we found that PPARg plays an anabolic role in vagal neu-
rons. Under normal dietary conditions, PPARg acts to suppress
EE, whereas upon acute exposure to HFD, its downregulation in
vagal sensory neurons promotes diet-induced thermogenesis
and may serve as an early protective mechanism against HFD-
induced weight gain. These results are reminiscent of recent
findings that mice lacking PPARg in all neurons were also pro-
tected from HFD-induced obesity, but due to a combination of
reduced feeding and increased EE (Lu et al., 2011). We hypoth-
esize that the absence of a feeding phenotype in PPARgPhox2b KO
mice is likely due to the fact that our manipulations spare PPARg
function in other (e.g., hypothalamic) neurons where it regulates
food intake (Diano et al., 2011; Ryan et al., 2011). On the other
hand, our findings demonstrate that vagal neurons serve as a
critical site where PPARg regulates EE. Interestingly, our obser-
vation that the EE increase was further exacerbated in HFD-fed
PPARgPhoxth2b KO mice suggests the involvement of additional
factors during diet-induced thermogenesis. Therefore, furtherCstudies are warranted to determine whether other NRs may
also contribute to the same process and play a role in the vagal
control of nutrient sensing and energy balance. Moreover, it
would be intriguing to study whether the functional outputs of
different NR programs in vagal afferents are segregated and
responsible for different aspects of vagal-mediated behaviors
(e.g., PPARa for food intake) (Tellez et al., 2013).
Many of thewhite adipocytes in PPARgPhox2b KOmice adopted
new morphologies and expressed biomarkers characteristic of
thermogenic brown adipocytes.We suspect that increased sym-
pathetic activity may underlie the browning of white adipocytes
(Cousin et al., 1992), as evidenced by a significant increase in
b3-adrenergic receptor expression in both BAT and subcutane-
ous WAT. Since both WAT and BAT receive innervation from
sympathetic, but not parasympathetic afferents (Bowers et al.,
2004), the increased EE in PPARgPhox2b KO mice is likely the
result of an increased sympathetic tone that is secondary to
altered input from the parasympathetic vagal sensory neurons.
The parasympathetic and sympathetic nervous systems interact
at multiple levels along the neural axis. For example, NTS neu-
rons not only receive and integrate metabolic signals from vagal
afferents but also regulate sympathetic output through relayell Metabolism 19, 722–730, April 1, 2014 ª2014 Elsevier Inc. 727
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Therefore, it is formally possible that PPARg deletion in other
Phox2b neurons including those in the NTS may contribute to
the observed responses. However, recent studies suggest that
EE can be directly affected by altered vagal sensory inputs
from the periphery. For example, direct intraduodenal infusion
of lipids increases EE in rats, a phenomenon that can be blunted
by blocking neurotransmission of intestinal vagal afferents
(Blouet and Schwartz, 2012). Similarly, Uno et al. (2006) reported
that the increased EE by hepatic gene manipulation can be
abolished by caspasin-mediated blockage of vagal afferents.
Despite its well-documented role in governing the transcrip-
tion of genes important for lipid synthesis and storage, little is
known about howPPARg functions in neurons to regulate neuro-
physiology. Our analysis demonstrated that PPARg regulates
the expression of its canonical transcriptional targets, including
Lpl, CD36, and aP2, in the NG neurons. Both Lpl and CD36 are
present in discrete neuronal populations within the CNS (Glezer
et al., 2009). Moreover, neuron-specific deletion of Lpl in mice
causes profound defects in energy balance and cognitive behav-
iors (Wang et al., 2011). Importantly, presynaptic deficits were
noted in Lpl-deficient hippocampal neurons that include the
depletion of synaptic vesicles as well as a reduction in presynap-
tic gene expression (Xian et al., 2009). Our analysis also revealed
a significant reduction in the expression of Gria2, a key compo-
nent of AMPA receptors, which has been implicated in control-
ling glutamate release at presynaptic terminals of sensory
afferents (Pinheiro and Mulle, 2008). Moreover, mRNAs of syn-
aptotagmin-4, an important modulator for transmitter exocytosis
(Zhang et al., 2011), was also reduced in PPARg-deficient NG
neurons. Our findings suggest the intriguing possibility that
defective lipid sensing in vagal sensory neurons may lead to
altered synaptic transmission. However, it remains to be deter-
mined whether the reduction of these presynaptic regulators is
secondary to an Lpl deficiency or whether PPARg directly regu-
lates their transcription in NG neurons.
Finally, we found that PPARgPhox2b KO mice have an enhanced
anorectic response to CCK administration, suggesting that
increased CCK receptor expression in PPARg-deficient NG neu-
rons affects vagal-mediated feeding behavior. In contrast, we
found no overall changes in food intake or meal patterns in
PPARgPhox2b KO mice despite the upregulation of CCK recep-
tors. This could be due to a compensatory mechanism triggered
by the embryonic deletion of PPARg in these mice. Similar ob-
servations were also made in CCKra null mice, which showed
normal food intake despite a blunted anorexic response to
acute CCK treatment (Kopin et al., 1999). In addition to its
anorexigenic action, CCKra activation is required for the in-
crease in EE seen after direct intraduodenal lipid infusion (Blouet
and Schwartz, 2012). Interestingly, we found a conserved PPAR
response element in the upstream regulatory sequences of
CCKra gene (396 bp upstream of exon 1), raising the possibility
that PPARg directly regulates its transcription in vagal sensory
neurons.
Altogether, our studies uncover a role for PPARg in vagal
neurons in sensing and relaying information of peripheral lipid
status toward the CNS. These findings further demonstrate
that PPARg-dependent lipid sensing by the vagus nerve is crit-
ical for the maintenance of long-term energy balance. The fact728 Cell Metabolism 19, 722–730, April 1, 2014 ª2014 Elsevier Inc.that vagal sensory neurons reside outside the blood-brain bar-
rier makes them potential targets for a number of pharmacolog-
ical agents. Moreover, there is emerging evidence that many
antidiabetic and antiobesity agents directly act on vagal affer-
ents, including agonists for the glucagon-like peptide 1 recep-
tor and cannabinoid 1 receptor (Burdyga et al., 2004; Vahl
et al., 2007). Therefore, studies on the roles of PPARg as well
as other NRs in vagal afferents will likely be a critical first
step in developing novel vagal-based antiobesity and antidia-
betic therapies.
EXPERIMENTAL PROCEDURES
Animals
All experimental procedures were approved by the Institutional Animal Care
and Use Committee at UT Southwestern Medical Center. Male mice heterozy-
gous for the floxed PPARg allele and hemizygous for the Phox2b::Cre trans-
gene were crossed with female mice homozygous for the floxed PPARg allele
to generate Phox2b::Cre ± ; PPARgfl/fl mice.
Laser Capture Microdissection
Nodose ganglia were cryosectioned (25 mm) using a cryostat and thaw-
mounted onto saline-coated PEN membrane glass slides (Applied Bio-
systems, Foster City). Slides were lightly fixed in 75% ethanol immediately
prior to thionin staining. Sections were then dehydrated in a series of graded
ethanol baths followed by 5 min in xylenes. The Arcturus Veritas Microdissec-
tion System (Applied Biosystems) was used to isolate the neuron-enriched
samples from the surrounding fibers and glial cells. RNA was extracted using
a PicoPure RNA Isolation Kit (Applied Biosystems) with an on-column DNase I
treatment to remove genomic contamination (QIAGEN, Valencia).
In Situ Hybridization
In situ hybridization was performed as described previously (Vianna et al.,
2012). The following primers were used to generate S35-UTP labeled
riboprobes for LXRa (50 GGATTCtgccatcagcatcttctctg 30; 50 ccgCTCCAGtctc
ctggctagtttatttgg 30), LXRb (50 GGATCCtgcagcagccatacgtgg 30; 50 ccgCTC
GAGtaacctctctccactcaagg 30), PPARa (50 AATCAGAGATGCCACCTTGG 30;
50 GGGGTCAAAGGCTGGTTAAT 30), and PPARg (50 CAGTGATATCGACCA
GCTGAA 30; 50 CATGAATCCTTGGCCCTCT 30).
Metabolic Cage Studies
Food intake, meal patterns, EE, and physical activity were continuously moni-
tored using a combined indirect calorimetry system (TSE Systems GmbH,
Bad Homburg, Germany). Experimental animals (11 weeks old) were accli-
mated in the metabolic chambers for 5 days before data collection. Mice
were initially maintained on chow diet during the acclimation and in the first
2 days of data collection and then fed HFD for the next 3 days in the
metabolic cages. O2 consumption and CO2 production were measured to
determine the EE. In addition, physical activity was measured using a multi-
dimensional infrared light bean system. Differences in EE before and after the
switch to HFD were calculated by subtracting the total EE of 24 hr before the
switch from that of 24 hr after the switch in each individual animal. All mice
demonstrated increases in EE after exposure to HFD. After the metabolic
cage analysis, mice were returned to their housing cages and fed again
with chow diet.
Food Restriction
Weight-matched experimental animals (n = 11, per genotype; 15 weeks old)
were singly housed for 7 days before the onset of food restriction, during which
body weight and food intake were measured daily. The average daily intake
during the 7 day period was then calculated for each individual mouse.
Following an overnight fast, mice were refed with only 60% of the amount of
their average daily consumption. Body weights and glucose levels were moni-
tored every single day during the restriction. Food restriction was carried out
for 7 days or terminated when individual mice lost more than 20% of their orig-
inal body weight according to the institutional guidelines.
Cell Metabolism
Vagal Control of Lipid Sensing and Energy BalanceCCK Administration
Experiments were performed as previously described by Fan et al. (2004).
Briefly, weight-matched PPARgPhox2b KO mice (n = 11) and their littermates
(n = 13) were used to test food intake in response to CCK-8 (Tocris, 10 mg/kg,
intraperitoneally) or saline after fasting for 16 hr with water available. Thirty
minutes after the injection, chow pellets are given to the singly housed mice,
and food intake was measured hourly for the next 6 hr.
Data Analysis
The data were represented as mean ±SEM as indicated in each figure legend.
Statistical analyses were performed using GraphPad PRISM version 6.0
(GraphPad, San Diego). After confirming normal distribution of data, compar-
isons between two genotypes were made by the unpaired Student’s t test.
Two-way ANOVA analyses were used to assess the interactions between
genotypes and treatments with relevant post hoc tests. Statistical analysis in
RT-qPCR experiment was carried out by using pairwise fixed reallocation
randomization test. p < 0.05 was considered to be statistically significant.
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